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To evaluate F and I yeast resistance in oropharyngal candidiasis in 
78 HIV patients, an oral swab was systematically collected for ev- 
ery patient from Mars to May 96. They were plated on Sabouraud 
dextrose agar. Yeasts were idended by Auxacolor (Diagnostics Pas- 
teur). F and I susceptibilities were determined on Casitone agar with 
E-test. Resistance was >8 mg/l for F, >4  for I .  The andfungal 
treatment during the proceedmg month was noted as well as the 
biological parameters. A yeast was isolated in 32 patients C+ (41%) 
and 8 (25%) had h c a l  signs. 10 (31%) had anthngal treatment 
(3 local amphotericine B and 6 oral fluconazole and 1 intravenous 
amphotericine B). No yeast was isolated in 46 patients C-; 7 (19%) 
had treatment (3 local and 4 oral F). No Merence was observed 
between the C+ and C- population for the clinical and biological 
state. No Merence was detected between the state of AIDS (A or 
C). 27 C. albicans (CA), 4 T. glabrata (TG), 1 C. tropicalis were iso- 
lated. Resistance was observed to F in 5 cases (15.6%): 3 TG, 2 CA. 
Cross resistance to F and I was observed in 4/5. Only one patient 
was under F therapy for cryptococcose (TG) and the other under 
Ampho B (CA). Our rate of yeast resistance to F and I is 15%. This 
resistance is not correlated with the state of illness. 
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Background: Disseminated c a n d i b  is a major nosocomial in- 
fection especially in immunocornpromised patients. Presently, blood 
culture and microscopy are the standard methods for detection of 
Candida sp, but dugnosis is often delayed due to the slow growth of 
the pathogen h m  dinical samples. Several studies seem to indicate 
that PCR might be a useful test for the early and sensitive detection 
of candidiasis. 
Method and Results: An improved method of DNA extraction 
fbm &cal samples based on a treatment with proteinase K and 
isolation of DNA on a silica membrane was developed. The targets 
used for DNA amplification are the Candida secreted aspartic pro- 
teinases (SAPS) genes, a multiple gene family of at least 7 members 
in C. albicans. A single pair of primers was designed in order to detect 
6 of these SAP genes and subsequently to increase the sensitivity of 
the test. The PCR product was then hybri&ed with a radioactive 
probe specific for the C. albicans SAP genes. A retrospective study 
was performed blindly on 94 clinical samples to compare the PCR 
ChCd Number Culture PCR S-blot False- "False- 
samples posruve poriuve pounve negruve pouuve" 
Blwddtu rc  47 22 20 21 1 0 
TO& 94 38 39 43 1 6 
'urine (n = 38). others (n = 9) 
Otbm' 47 16 19 22 0 6 
reSdk with those of culture. 
Conclusion: Compared with a previously developed assay based 
on the amplification of the lanosterol-demethylase gene (Bur- 
gener-Kairuz et al., JCM, 1994), this PCR assay is more sensitive 
(97%, single round PCR vs 76%, nested PCR), with a lower speci- 
ficity (89% vs 95%). This warrants a further prospective study with 
clinical specimens h m  patients at high risk for disseminated can- 
didiasis. 
1 P369 I Detection of Candida albicans by DNA 
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Kuwait University, Kuwait 
Objectives: To establish genus specific PCR and species specific 
nested PCR assays for specific identification of Merent Candida 
species and to test the suitability of PCR for detection of Candida 
in &nical specimens. 
Methob  DNA segments from the gene encoding cytochmme 
P450LlA1 were targeted for amplification by using genus and species 
specific primers. The yeast DNA was extracted fiom overmght 
grown cells using standard lysis b d e r  followed by DNA extraction 
by phenol and chloroform. Yeast lysis buffer containing zymolase was 
used to extract DNA from clinical specimens. Amplification condi- 
tions were standardized with respect to the concentration of MgCl2, 
anneahng temperature and DMSO. Amplified products were ana- 
lyzed by gel electrophoresis. 
Results: The genus speclfic primers (ZU5/ZU6) and the species 
specific primers (ZUS/ZU7) amplified 496 bp and 418 bp DNA, 
respectively, f b m  the genomic DNA of C. albicam. Species specific 
nested PCR improved the sensitivity of genus specific PCR by 1000 
times. A total of 21 specimens (2 urine + 19 blood) f b m  19 im- 
munocompromised subjeca were tested by culture and PCR. Both 
the tests were positive with 4 specimens. One specimen was culture 
positive but nested PCR negative whereas 4 specimens were nested 
PCR positive for C. albicans but culture negative. 
Conclusions: The nested PCR is a sensitive technique to detect 
C. albicans and other Candida species directly in clinical specimens. 
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Objectives: Deep mycotic infections are life threatening complica- 
tions in intensive cancer therapy but their dmgnostics is unsatisfac- 
tory. We have hied to develop a new test based on PCR method 
and have evaluated ik sensitidy and specificity. 
Methods: The primers were derived &om the fungus-specific re- 
gions of the I8SrDNA gene amp-g a 673 bp diagnostic Merit 
TAGGATAG-3). The blood samples have been drawn immediately 
after death and for the further analysis the whole blood was used. In 
(5-TGATCATCTTCGATCCCCTA-3 and 5-ACTTTCGATGG 
Autopsy PCR 
Poriuve (number of patients) Negative (number of pauents) 
PoritiW 11 
Negative 1 
1 
11 
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order to increase sensitivity we combined PCR with Southern blot. 
Results: There were 28 cancer patients examined by both PCR 
and d e d e d  autopsy ( m d y  leukemias and lymphomas). The results 
are given in the table. Only unambiguous findmgs are listed. 
There were 2 disseminated Candida infections and 9 localized 
mycotic infections, mainly mucositis. One Aspergillus pneumonia was 
missed by PCR test. 
Conclusions: Sensitivity, specdicity, positive as well as negative 
predictive value of our PCR test are 92%. This results are very 
encouraging. Nevertheless, this test is so far not suitable for routine 
usage because it is very time consuming. 
ily. FLUl encodes a protein of 67.6 kDa whose predicted structural 
organmation is characterized by 12 potential transmembrane spans. 
FLUl is expressed at similar levels in fluconazole resistant and sus- 
ceptible strains in C. albicans clinical isolates. The overexpression of 
FLUl in the S. cerevitiae multidrug transporter mutant Apdr5 leads to 
an increased resistance to fluconazole and cycloheximide. Disruption 
of FLUl in different C. albicans strains resulted in a slight increase of 
susceptibility to azole annhngal agents. 
Conclusion: The transporter Flulp, which belongs to the class 
of ME is implicated in the transport of fluconazole in the yeast C. 
albicans. 
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Resistant Isolates 
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101 1 Lausanne, Switzerland 
C. glabrata is a yeast often isolated &om AIDS patients with 
oropharyngeal candidiasis (OPC) treated with azole antifungal 
agents, and especially with fluconazole. It is known that C. glabrata 
isolates are intrinsically less susceptible to fluconazole than C. al- 
bicans. Several pairs of C. glabratn dinical isolates with increasing 
in uitro resistance to fluconazole and cross-resistance to itraconazole 
and ketoconazole have been isolated and the molecular resistance 
mechanisms investigated. Since fluconazole accumulation was much 
reduced in resistant isolates, the expression of multidrug transporter 
genes was examined in the azole susceptible and azole resistant yeasts. 
First, C. glabratagenes conferring resistance to a Sacharomyces c e d i a e  
Apdr5 null mutant were cloned. Three different genes were isolated 
a gene (CgCDR) similar to the C. albicans CDRI ABC-transporter 
gene, a gene (CgBEN) similar to the C. albicans BEN gene and a 
gene (CgYAP1) s d a r  to the S. cerwisiae YAP1 encoding a tran- 
scription factor. We could observed that i) CgBEN was constitu- 
tively expressed in both the azole susceptible and resistant isolates, 
thus probably accounting for the intrinsic reduced susceptibility of 
C. gfabrata to fluconazole and that ii) CgCDR was overexpressed by 
a factor of 5 to 8 in the resistant isolates, thus contributing for the 
cross-resistance to the azole derivatives examined in this study. 
(p3721 Characterization of FLUT, a Novel Multidmg 
Efflux Transporter Gene from Candida albicans 
D.C. Calabrese, J. Bille, D. Sanglard. Institut de Minobiologie, Centre 
Hospitalier Universitaire Vaudois, 101 1 husanne, Switzerland 
Objectives: Identification of resistance mechanisms to azole anti- 
fungal agents and particularly to fluconazole in c. albicans. 
Methods: Mechanisms of resistance to azole andfungal agents in 
C. albirans involve at least muItidrug transporters belonging to the 
class of ATP-binding-cassette (ABC) transporters and to the class of 
Major Facilitators (MF). 
Three of these genes that were shown to participate in 
these resistance mechanism have been previously cloned: The 
ABC-transporter genes CDRI, CDR2 and the MF gene B E N .  
To isolate additional factors potentially responsible for resistance to 
azole antifungal agents in C. albicans, a genomic library &om this 
organism was used to complement the fluconazole hypersusceptibil- 
ity of a Saahnromycs cerevisiae multidrug transporter mutant Apdr5, 
lacking the ABC-transporter Pdr5p. 
Results: By functional complementation of a S. cerevisiae Apdr5 
null mutant, a new gene was cloned and was named FLU1. The 
nucleotide sequence of FLUl revealed high urmlarity to a putative 
membrane transporter, like BEW, belonging to the MF superfam- 
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Fluconazole resistant C. albicans isolates &om AIDS patients with 
oropharyngeal canddiasis have been used to investigate the molec- 
ular basis of resistance to azole antdimgal agents. Multidrug efflux 
transporters were shown to play an important role in the appearance 
of resistance, but other mechanisms could be involved. We therefore 
analysed more closely changes in &nity of azole antifungal agents 
to their cellular target (CYF'51A1) as a likely possible factor. Func- 
tional expression of the C. albicans CYPSlA 1 genes &om sequential 
clinical isolates &om patients was achieved in Saccharomyces cerevisiae. 
This selection enabled the detection of 4 different mutations in the 
Herent cloned CYP5lA1 genes affecting selectively the Anity of 
azole derivatives to their target. We speculate that these specific mu- 
tations combined to the effect of multidrug efflux transporters in the 
c h c a l  isolates, thus contributing probably to different patterns and 
degrees of resistance to azole derivatives. 
A Rapid Colorimetric Method for the Study of 
Resistance Mechanisms to Azole Antifungal 
Agents in Yeasts 
D. Sanglard, P. Majcherczyk, E Ischer, J. Bille. Centre Hospitalier 
Uniuersitnire kudois, 101 1 Lausanne, Switzerland 
For a broad screening of yeast resistance to azole antifungal agents 
for the study of mechanisms of resistance, simple methods able to 
discriminate between diEerent mechanisms of resistance have to be 
designed. Since several resistant isolates &om Merent yeast species 
failed to accumulate azole derivatives due to specdic multidrug efflux 
transporters, a rapid method that could demonstrate the activity of 
such transporters was assayed. We found that the level of accumula- 
tion of the fluorochrome Rhodamine 6G (R6G) was a good marker 
for the presence of multidrug efflux transporter of the ATP-binding 
Cassette (ABC) family. After a short incubation time of yeast cells 
(C. albicans, C. glabrata) susceptible or resistant to fluconazole or other 
azole derivatives with R6G, cells could be examined by FACS analy- 
sis or more simply by fluorescence microscopy. Yeast cross-resistant to 
azole derivatives and overexpressing ABC-transporter genes ctd not 
accumulate the levels of R6G reached by susceptible isolates. Yeasts 
specifically resistant to fluconazole contained similar R6G concen- 
trations to those of fluconazole susceptible strains, thus indicating 
that another fluconazole efflux mechanism (e.g. the overexpression 
of the Major Fachtator BEN) was present in these strains. 
